Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 401–500 of 999
Annavajhala, M. K., May, M. S., Compres, G., Freedberg, D. E., Graham, R., Stump, S., Que, J., Korem, T., Uhlemann, A., & Abrams, J. A. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000235 · Cited by 34
“In the colon, bio fi lms are present on proximal tumors and adjacent paired normal mucosa (15) and promote the development of colonic neoplasia in mice (16).”
Human Microbiome and Its Medical Applications
Zhang, Y., Zhou, L., Xia, J., Dong, C., & Luo, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.703585 · Cited by 32
“For example, in colorectal cancer (CRC), Bacteroides fragilis could destroy the colonic mucosal protective layer by releasing toxins which led to tumorigenesis (Dejea et al., 2018).”
BackgroundThe gut microbiota can orchestrate the signaling pathways in colorectal cancer
Bennedsen, A. L. B., Furbo, S., Bjarnsholt, T., Raskov, H., Gögenür, I., & Kvich, L. (2022) · Apmis · doi:10.1111/apm.13206 · Cited by 34
Zhang, T., Deng, Y., Yang, S. L., Chua, S. L., Tang, B. Z., & Khoo, B. L. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137579 · Cited by 31
Queen, J., Shaikh, F. Y., & Sears, C. L. (2023) · Nature Cancer · doi:10.1038/s43018-023-00602-2 · Cited by 36
Self-citationKrieg, C., Weber, L. M., Fosso, B., Marzano, M., Hardiman, G., Olcina, M. M., Domingo, E., Aidy, S. E., Mallah, K., Robinson, M. D., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004717 · Cited by 30
Bacterial infection and microbiota in carcinogenesis and tumor development
Li, Q. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1294082 · Cited by 34
Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier
Liu, Y., Huang, W., Wang, J., Ma, J., Zhang, M., Lü, X., Liu, J., & Kou, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693479 · Cited by 38
“It was biologically more plausible that oral fusobacteria spread to CRC through hematogenous route, because Fusobacteria was absent from biofilms in the colonic mucous layer of adenomas of familial adenomatous polyposis patients and some sporadic CRC patients (32).”
BackgroundCirculating microbiome DNA: An emerging paradigm for cancer liquid biopsy
Chen, H., Ma, Y., Liu, Z., Li, J., Li, X., Yang, F., & Qiu, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.036 · Cited by 35
Tumor-resident microbes: the new kids on the microenvironment block
Li, L., Chandra, V., & McAllister, F. (2024) · Trends in Cancer · doi:10.1016/j.trecan.2023.12.002 · Cited by 30
“ETBF is increased in precancerous CRC lesions such as familial adenomatous polyposis (FAP) [19] and promotes colonic tumorigenesis by increasing interleukin-17 (IL-17)-dependent signaling in immune and tumor cells [20,21].”
BackgroundInfluence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
“…urogenital tracts, mainly through the secretion of genotoxins, such as colibactin toxin from pks + Escherichia coli and toxins from B. fragilis [236–239]; (2) affect chemotherapy resistance either directly via microbial metabolism (e.g., gemcitabine degradation by cytidine deaminase in pancreatic…”
BackgroundThe intratumoural microbiota in cancer: new insights from inside
An, Y., Zhang, W., Liu, T., Wang, B., & Cao, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188626 · Cited by 29
Iwasaki, M., Kanehara, R., Yamaji, T., Katagiri, R., Mutoh, M., Tsunematsu, Y., Sato, M., Watanabe, K., Hosomi, K., Kakugawa, Y., et al. (2021) · Cancer Science · doi:10.1111/cas.15196 · Cited by 34
Yin, F., Zhou, X., Kang, S., Li, X., Li, J., Ullah, I., Zhang, A., Sun, H. J., & Wang, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115286 · Cited by 30
Png, C. W., Chua, Y. K., Law, J.-H., Zhang, Y., & Tan, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-14203-z · Cited by 32
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Modica, M. D., Arlotta, V., Sfondrini, L., Tagliabue, E., & Triulzi, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947188 · Cited by 36
Bosch, D. E., Abbasian, R., Parajuli, B., Peterson, S. B., & Mougous, J. D. (2023) · mBio · doi:10.1128/mbio.01039-23 · Cited by 39
Guo, X., & Shao, Y. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01166-w · Cited by 36
“…AE et al. found that the arginine protease 4 (Rgp4) from the “red complex,” which includes P. gingivalis , Tannerella forsythia , and Treponema denticola , disrupts p53-ING4 binding, suppresses p53 acetylation, and consequently inhibits downstream p21 expression and function (Dejea et al. 2018).”
Kan, L., Yu, Y., Wang, Y., Shi, L., Fan, T., Chen, H., & Ren, C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02328-4 · Cited by 33
Bacterial biofilm formation inside colonic crypts may accelerate colorectal carcinogenesis
Raskov, H., Kragh, K. N., Bjarnsholt, T., Alamili, M., & Gögenür, I. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0209-2 · Cited by 30
“report colonization of aggregated bacteria (biofilms) consisting of ETBF and CPEC on the colonic epithelial surface in patients with familial adenomatous polyposis coli (FAP) [3].”
BackgroundInfluentialIntestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma
Jiang, H., Li, J., Zhang, B., Huang, R., Zhang, J., Chen, Z., Shang, X., Li, X., & Nie, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01346 · Cited by 34
“It is worth noting that patients with familial colorectal cancer have similar imbalanced intestinal flora structures (17), which may cause a metabolic disruption of the intestinal metabolites and the disorders of the immune system, leading to cancer.”
BackgroundCrypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome
Lang, M., Baumgartner, M., Rożalska, A., Frick, A. P., Riva, A., Jarek, M., Berry, D., & Gasché, C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33028 · Cited by 35
“In FAP, biofilms are not restricted to polyps, but are present as patchy biofilms within the normal colonic mucosa.(6) These biofilms predominately contain tumorigenic bacteria such as pks + Escherichia coli and enterotoxigenic”
BackgroundGut microbiome in tumorigenesis and therapy of colorectal cancer
Wang, L., Yu, K., Hou, Y., Guo, M., Yao, F., & Chen, Z. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30917 · Cited by 32
“E. coli expressing colibactin causes DNA crosslink and double‐stranded DNA breaks (Dejea et al., 2018).”
BackgroundThe Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
Yu, I., Wu, R., Tokumaru, Y., Terracina, K. P., & Takabe, K. (2022) · Cancers · doi:10.3390/cancers14225685 · Cited by 34
Wei, Y., Huang, N., Ye, X., Liu, M., Wei, M., & Huang, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1103463 · Cited by 31
What We Still Don’t Know About Biofilms—Current Overview and Key Research Information
Damyanova, T., & Paunova-Krasteva, T. S. (2025) · Microbiology Research · doi:10.3390/microbiolres16020046 · Cited by 36
Revealing a microbial carcinogen
Bleich, R. M., & Arthur, J. C. (2019) · Science · doi:10.1126/science.aaw5475 · Cited by 29
Unveiling the Mutational Mechanism of the Bacterial Genotoxin Colibactin in Colorectal Cancer
Thakur, B. K., Malaisé, Y., & Martín, A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.007 · Cited by 29
Sheikh, A. A., Taube, J. H., & Greathouse, K. L. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab060 · Cited by 32
Cheng, K.-W., Tseng, C.-H., Chen, I., Huang, B.-C., Liu, H.-J., Ho, K., Lin, W., Chuang, C.-H., Huang, M., Leu, Y.-L., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106115 · Cited by 28
Wang, K., Lo, C., Mehta, R. S., Nguyen, L. H., Wang, Y., Ma, W., Ugai, T., Kawamura, H., Ugai, S., Takashima, Y., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.07.040 · Cited by 32
Self-citationRetractedWu, Y., Shi, L., Li, Q., Wu, J., Peng, W., Li, H., Chen, K., Ren, Y., & Fu, X. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1578394 · Cited by 30
“coli together can form a biofilm that damages the colon epithelium and causes CRC (31).”
BackgroundWolf in Sheep’s Clothing: Clostridioides difficile Biofilm as a Reservoir for Recurrent Infections
Meza‐Torres, J., Auria, E., Dupuy, B., & Tremblay, Y. D. N. (2021) · Microorganisms · doi:10.3390/microorganisms9091922 · Cited by 31
“Furthermore, mice co-colonized with oncotoxin-producing strains had an increase in IL-17 production in the colon and increased DNA damage in colonic epithelial cells leading to faster onset of tumor [55] creation.”
BackgroundCao, K., Pan, Y., Yan, T., Tao, P., Xiao, Y., & Jiang, Z. (2022) · mSystems · doi:10.1128/msystems.00164-22 · Cited by 29
Effect of gut microbiota in the colorectal cancer and potential target therapy
Li, J., Zhu, Y., Yang, L., & Wang, Z. (2022) · Discover Oncology · doi:10.1007/s12672-022-00517-x · Cited by 29
“fragilis, which can have a role in tumour progression [15].”
BackgroundIn vitro and ex vivo modeling of enteric bacterial infections
Taebnia, N., Römling, U., & Lauschke, V. M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2158034 · Cited by 30
Intratumoural microbiota: from theory to clinical application
Ji, H., Jiang, Z., Wei, C., Ma, Y., Zhao, J., Wang, F., Zhao, B., Wang, D., & Tang, D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01134-z · Cited by 29
“Enterotoxin-producing Bacteroides fragilis (ETBF) ETBF promotes cancer development by recruiting other bacteria and immune cells to the tumor site and promoting IL-17-mediated inflammation [19]”
BackgroundModel Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria
Shine, E. E., Xue, M., Patel, J. R., Healy, A. R., Surovtseva, Y. V., Herzon, S. B., & Crawford, J. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00714 · Cited by 27
Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis
Ditonno, I., Novielli, D., Celiberto, F., Rizzi, S., Rendina, M. G., Ierardi, E., Leo, A. D., & Losurdo, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065687 · Cited by 33
“Biofilm Polyps and macroscopically normal tissue of FAP patient were labeled with a panbacterial 16S rRNA fluorescence in situ hybridization probe, then specific pathogen-free wild-type AOM-treated mice were mono- or co-inoculated with strains identified in FAP patients [47]”
BackgroundMethodAdvancements in synthetic biology-based bacterial cancer therapy: A modular design approach
Arboleda-García, A., Alarcon‐Ruiz, I., Boada-Acosta, L., Boada, Y., Vignoni, A., & Lewintre, E. J. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104088 · Cited by 29
P. aeruginosa interactions with other microbes in biofilms during co-infection
Oliveira, M., Cunha, E. S., Tavares, L. M., & Serrano, I. D. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023032 · Cited by 33
“fragilis biofilms co-colonize the colon, which is associated with an enhanced morbidity and mortality [63,86].”
BackgroundCurrent understandings of colibactin regulation
Addington, E., Sandalli, S., & Roe, A. J. (2024) · Microbiology · doi:10.1099/mic.0.001427 · Cited by 27
“In fact, it is estimated that 20–22 % of healthy individuals are colonised by pks+ E. coli [10, 11].”
BackgroundAhmad, A., Mahmood, N., Raza, M. A., Mushtaq, Z., Saeed, F., Afzaal, M., Hussain, M., Amjad, H., & Al-Awadi, H. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29495 · Cited by 34
“A study conducted by Dejea et al. [148], reported that ETBF and pks + E. coli synergistically take part in DNA damage and tumor formation in mouse models.”
MethodPedrogo, D. A. M., Sears, C. L., & Melia, J. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae061 · Cited by 32
Self-citationMohammadi, M., Mirzaei, H., & Motallebi, M. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102501 · Cited by 29
Barchi, A., Massimino, L., Mandarino, F. V., Vespa, E., Sinagra, E., Almolla, O., Passaretti, S. M., Fasulo, E., Parigi, T. L., Cagliani, S., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.026 · Cited by 33
“Such focal effect of C. concisus colonization could explain a local bacterial adhesion facilitated by a biofilm formation, a phenomenon that can be found also in oral and colonic pathology [57].”
Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa
Lawrence, G. W., Begley, M., Cotter, P. D., & Guinane, C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030924 · Cited by 25
Yoshikawa, Y., Tsunematsu, Y., Matsuzaki, N., Hirayama, Y., Higashiguchi, F., Sato, M., Iwashita, Y., Miyoshi, N., Mutoh, M., Ishikawa, H., et al. (2020) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.066 · Cited by 27
The tumour-associated microbiome
Johnston, C. D., & Bullman, S. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00609-7 · Cited by 31
Yuan, D., Tao, Y., Wang, H., Wang, J., Cao, Y., Cao, G., Pan, S., & Yu, Z. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01263-1 · Cited by 29
“Previous studies have shown that dysbiosis and imbalance in the gut microbiome can mediate or alter the impact of environmental factors on CRC risk [19, 20].”
BackgroundSelf-citationImplication of gut microbes and its metabolites in colorectal cancer
Kumar, A., Ali, A., Kapardar, R. K., Dar, G. M., Nimisha, Apurva, A., Sharma, A. K., Verma, R., Sattar, R. S. A., Ahmad, E., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04422-2 · Cited by 26
Holt, R. A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2022.11.014 · Cited by 26
Gut microbiome: decision-makers in the microenvironment of colorectal cancer
Han, J., Zhang, B., Zhang, Y., Yin, T., Cui, Y., Liu, J., Yang, Y., Song, H., & Shang, D. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1299977 · Cited by 27
Chen, Y., Yang, Y., & Gu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s240108 · Cited by 28
“Even familial colorectal polyposis with a genetic predisposition may develop early carcinogenesis due to epithelial damage caused by interactions between specific intestinal bacterial types and interleukin-17.(14) Some investigators have questioned the vital role of the microbiome, reporting intestinal microbial chang…”
BackgroundGeorgeson, P., Steinfelder, R. S., Harrison, T. A., Pope, B. J., Zaidi, S. H. E., Qu, C., Lin, Y., Joo, J. E., Mahmood, K., Clendenning, M., et al. (2023) · medRxiv · doi:10.1101/2023.03.10.23287127 · Cited by 29
“…of genotoxic strains of Escherichia coli harboring the pks island ( pks + E. coli ) in CRC-affected individuals compared with healthy individuals 10–12 and, more recently, a western-style diet was found to be associated with a higher incidence of CRC containing pks + E. coli 13 , further…”
Wang, Z., Liang, L., Liu, L., Wang, Z., Wang, Y., Yu, Z., Wu, B., & Chen, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02819-22 · Cited by 23
“Escherichia coli harboring the genomic island polyketide synthase (pks1) was an essential component of bacterial biofilms found in the intestinal mucosae of patients with familial adenomatous polyposis (FAP) (18).”
BackgroundInfluentialMicrobiota and metabolism: what's new in 2018?
Bretin, A., Gewirtz, A. T., & Chassaing, B. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2018 · Cited by 26
“Interestingly, alterations in mucus-associated microbiota precede the onset of intestinal inflammation in the Mdr1a / mouse model, and a recent publication in Science reports that biofilms at the surface of the colonic epithelium are involved in colon carcinogenesis (18), further supporting the important role that thi…”
BackgroundBacteria-related changes in host DNA methylation and the risk for CRC
Sobhani, I., Rotkopf, H., & Khazaie, K. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1800898 · Cited by 26
“coli works synergistically with fragilysin a toxin produced by enterotoxigenic Bacteroides fragilis (ETBF), to damage DNA in colonocytes and stimulate proinflammatory response in mice.(88) Overall, and at the genus level, 20–30 bacterial genera have been found to be significantly different between CRC patients and con…”
BackgroundMicrobe-Driven Genotoxicity in Gastrointestinal Carcinogenesis
Hartl, K., & Sigal, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207439 · Cited by 25
Tomkovich, S., Taylor, A., King, J., Colovas, J., Bishop, L., McBride, K., Royzenblat, S. K., Lesniak, N. A., Bergin, I. L., & Schloss, P. D. (2021) · mSphere · doi:10.1128/msphere.00629-21 · Cited by 24
Colorectal Cancer and Purinergic Signalling: An Overview
Roliano, G. G., Azambuja, J. H., Brunetto, V., Butterfield, H. E., Kalil, A. N., & Braganhol, E. (2022) · Cancers · doi:10.3390/cancers14194887 · Cited by 27
“The potential for the gut microbiome to directly contribute to tumorigenesis has recently been recognized [37].”
InfluentialIntratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 28
Sun, L., Qu, J., Ke, X., Zhang, Y., Xu, H., Lv, N., Leng, J., Zhang, Y., Guan, A., Feng, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1229888 · Cited by 26
Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer
Mori, G., & Pasca, M. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031312 · Cited by 30
Zhou, T., Hirayama, Y., Tsunematsu, Y., Suzuki, N., Tanaka, S., Uchiyama, N., Goda, Y., Yoshikawa, Y., Iwashita, Y., Sato, M., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c01495 · Cited by 26
The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression
Souza, V. G. P., Forder, A., Pewarchuk, M. E., Telkar, N., de Araújo, R. P., Stewart, G. L., Vieira, J., Reis, P. P., & Lam, W. L. (2023) · Cells · doi:10.3390/cells12242801 · Cited by 31
“The intratumor microbiome is a major constituent of the TME, wielding a substantial influence on various aspects of cancer dynamics, including the tumorigenesis, disease progression, drug resistance, and prognosis [138–140].”
BackgroundModeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
Moskal, K., Khurana, N., Siegert, L., Lee, Y., Clevers, H. C., Elinav, E., & Puschhof, J. (2024) · International Journal of Cancer · doi:10.1002/ijc.35298 · Cited by 25
“13,19 22 Thus, in vitro systems, particularly advanced co-culture models, have emerged as valuable additions.”
InfluentialThe Impact of Intraspecies and Interspecies Bacterial Interactions on Disease Outcome
Baishya, J., Bisht, K., Rimbey, J. N., Yihunie, K. D., Islam, S., Mahmud, H. A., Waller, J., & Wakeman, C. A. (2021) · Pathogens · doi:10.3390/pathogens10020096 · Cited by 27
“Unsurprisingly, the complex microbial make-up of the human intestinal tract is also subject to pathogenic syn rgy [50].”
BackgroundMicrobiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease
Poudel, S. K., Padmanabhan, R., Dave, H. M., Guinta, K. M., Stevens, T., Sanaka, M. R., Chahal, P., Sohal, D. P. S., Khorana, A. A., & Eng, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283021 · Cited by 27
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
Zhang, J., Wang, P., Wang, J., Wei, X., & Wang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107185 · Cited by 26
Oral hygiene might prevent cancer
Cordero, O. J., & Varela‐Calviño, R. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00879 · Cited by 28
Terlouw, D., Suerink, M., Singh, S. S., Gille, H. J. J. P., Hes, F. J., Langers, A. M. J., Morreau, H. M., Vasen, H. F. A., Vos, Y. J., van Wezel, T., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0509-z · Cited by 22
Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature
Lopes, M. S. M., Machado, L. M., Silva, P. A. I. A., Uchiyama, A. A. T., Yen, C. T., Ricardo, E. D., Mutão, T. S., Pimento, J. R., Shimba, D. S., Hanriot, R. D. M., et al. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1106 · Cited by 30
A tale of two bacteria – Bacteroides fragilis, Escherichia coli, and colorectal cancer
Lichtenstern, C. R., & Lamichhane-Khadka, R. (2023) · Frontiers in Bacteriology · doi:10.3389/fbrio.2023.1229077 · Cited by 23
Zhang, G., & Sun, D. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1501973 · Cited by 25
Cancer microbiota: a focus on tumor-resident bacteria
Vella, G., & Rescigno, M. (2025) · EMBO Reports · doi:10.1038/s44319-025-00482-w · Cited by 26
“Enterotoxigenic Bacteroides fragilis (ETBF) is enriched in precancerous lesions, particularly in familial adenomatous poly-posis (FAP) patients (Dejea et al, 2018).”
Inferring Bacterial Infiltration in Primary Colorectal Tumors From Host Whole Genome Sequencing Data
Guo, M., Xu, E., & Ai, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00213 · Cited by 25
Xie, X., Jiang, D., Zhou, X., Ye, X., Yang, P. X., & He, Y. (2021) · Open Life Sciences · doi:10.1515/biol-2021-0043 · Cited by 22
“fragilis are the two dominant and persistent colonizers in the CRC patients’ fecal and colonic mucosal samples [18].”
BackgroundEmerging Complexity in CD4+T Lineage Programming and Its Implications in Colorectal Cancer
Ditoro, D. F., & Basu, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694833 · Cited by 25
Vitali, F., Tortora, K., Paola, M. D., Bartolucci, G., Menicatti, M., Filippo, C. D., & Caderni, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-05249-0 · Cited by 27
Welham, Z., Li, J., Engel, A. F., & Molloy, M. P. (2023) · Cancers · doi:10.3390/cancers15205045 · Cited by 25
Recent progress in experimental and human disease-associated multi-species biofilms
Bai, F., Cai, Z., & Yang, L. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.010 · Cited by 26
“coli which promotes DNA damage by colibactin in epithelial cells and interleukin-17 induction [91].”
BackgroundYu, Z., Yue, L., Yang, Z., Wang, Y., Wang, Z., Zhou, F., Li, C., Li, L., Zhang, W., & Li, X. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106329 · Cited by 23
Interactions between the tumor microbiota and breast cancer
Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 29
“Certain carcinogenic bacteria, such as pks+ Escherichia coli and Staphylococcus aureus , encode and secrete cytolytic toxins (e.g., colibactin, PSM a 1-4) that cause ROS-mediated DNA damage and accelerate tumor onset (Dejea et al., 2018; Krueger et al., 2022).”
Harnessing the microbiome for cancer therapy
Hajjar, R., Mars, R. A. T., & Kashyap, P. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01268-6 · Cited by 34
“…ETBF, enterotoxigenic B. fragilis ; IL, interleukin; LCN, lipocalin; LPS, lipopolysaccharides; MMP, matrix metalloproteinase; MUC2, mucin 2; NF-κB, nuclear factor-κB; ROS, reactive oxygen species; PGN, peptidoglycan; TNF, tumour necrosis factor 9,22,28,45,46,49–52, Review article desired location.”
Wang, X., Undi, R. B., Ali, N., & Huycke, M. M. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048793 · Cited by 22
Biondi, A., Basile, F., & Vacante, M. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i6.495 · Cited by 26
Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers
Kouzu, K., Tsujimoto, H., Kishi, Y., Ueno, H., & Shinomiya, N. (2021) · Medicines · doi:10.3390/medicines8080045 · Cited by 22
“Colibactin-related colonic epithelial cell DNA damage reportedly results in tumor induction in patients with familial adenomatous polyposis [74].”
BackgroundA Multi-Omics Study of Familial Lung Cancer: Microbiome and Host Gene Expression Patterns
Chen, Y., Huang, Y., Ding, X., Yang, Z., He, L. M., Ning, M., Yang, Z., He, D., Yang, L., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827953 · Cited by 27
“For both normal and cancer tissue, gene mutations might allow pathogenic species to dominate the community or increase the virulence of other normally commensal microbes; as one study noted: Apc mutation enhances mucosal bacterial adherence (75).”
BackgroundHydrogels for Antitumor and Antibacterial Therapy
Fang, X., Wang, C., Zhou, S., Cui, P., Hu, H., Ni, X., Jiang, P., & Wang, J. (2022) · Gels · doi:10.3390/gels8050315 · Cited by 22
“Moreover, the suboptimal immunity of cancer patients may increase the chance of bacterial or fungal infections, leading to a high recurrence rate of cancer [150,151].”
BackgroundDysbiosis: The first hit for digestive system cancer
Mei, S., Deng, Z., Chen, Y., Ning, D.-M., Guo, Y., Fan, X., Wang, R., Meng, Y., Zhou, Q., & Tian, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1040991 · Cited by 25
Tanaka, S., HAMMOND, B. F., Rosin, D. L., & Okusa, M. D. (2019) · Bioelectronic Medicine · doi:10.1186/s42234-019-0029-8 · Cited by 24
Suresh, A., Shaik, S., Baddam, R., Ranjan, A. K., Qumar, S., Jadhav, S., Semmler, T., Ghazi, I. A., Wieler, L. H., & Ahmed, N. (2021) · mBio · doi:10.1128/mbio.03634-20 · Cited by 25
“dation, followed by adherence and augmented colonization (19).”
Liu, Z., Parida, S., Prasad, R., Pandey, R., Sharma, D., & Barman, I. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.004 · Cited by 24
Biswas, T., Ahmed, M. A., & Mondal, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106866 · Cited by 27
Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary
Barnich, N., Arthur, J. C., Buisson, A., Campbell, B. J., Carbonnel, F., Chassaing, B., Coombes, B. K., Denizot, J., Dogan, B., Faith, J. J., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-335331 · Cited by 29
Chen, X., Luo, Q., Ding, J., Yang, M., Zhang, R., & Chen, F. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00315-6 · Cited by 22
Precision strategies for cancer treatment by modifying the tumor-related bacteria
Lu, H., Wang, Q., Liu, W., Wen, Z., & Li, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11491-9 · Cited by 22
The Role of Gut Microbiota in Gastrointestinal Tract Cancers
Grochowska, M., Perlejewski, K., Laskus, T., & Radkowski, M. (2022) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-021-00641-6 · Cited by 23
Colon mucus in colorectal neoplasia and beyond
Loktionov, A. S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i32.4475 · Cited by 21
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.